← Back to Search

Behavioral Testing for Neurosciences

N/A
Recruiting
Led By Ziv Williams, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years old or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 minutes
Awards & highlights

Study Summary

This trial will study how the prefrontal cortex affects social cognition in humans.

Who is the study for?
This trial is for adults over 18 who can consent to participate. It's not suitable for those under 18, pregnant individuals, people with significant other illnesses, or those on medications that affect the brain like stimulants and antipsychotics. Also excluded are those with claustrophobia or anxiety that could interfere with testing.Check my eligibility
What is being tested?
The study focuses on how a part of the brain called the dorsal prefrontal cortex is involved in social thinking and behavior. Participants will undergo behavioral tests while their brain activity is recorded.See study design
What are the potential side effects?
Since this study involves behavioral testing rather than medication, traditional side effects are not expected. However, participants may experience discomfort or anxiety during neuronal recordings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of neurons displaying changes in activity related to task events
Secondary outcome measures
Percentage of task events that can be correctly predicted from neuronal activity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neurosurgical subjectsExperimental Treatment1 Intervention
Subjects undergoing intracranial neurosurgical procedures

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,924 Previous Clinical Trials
13,193,403 Total Patients Enrolled
Brown UniversityOTHER
454 Previous Clinical Trials
562,791 Total Patients Enrolled
Ziv Williams, MDPrincipal InvestigatorMassachusetts General Hospital

Media Library

Behavioral testing during neuronal recordings Clinical Trial Eligibility Overview. Trial Name: NCT05324579 — N/A
Neurosciences Research Study Groups: Neurosurgical subjects
Neurosciences Clinical Trial 2023: Behavioral testing during neuronal recordings Highlights & Side Effects. Trial Name: NCT05324579 — N/A
Behavioral testing during neuronal recordings 2023 Treatment Timeline for Medical Study. Trial Name: NCT05324579 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any spots available for this trial at present?

"That is correct. Data hosted on clinicaltrials.gov verifies that this scientific study, which was originally posted on May 20th 2022, is actively recruiting participants. Approximately 20 patients must be recruited from 2 distinct medical facilities."

Answered by AI

What is the current enrollment of this scientific experiment?

"Affirmative. Clinicaltrials.gov verifies that, as of today, this trial is searching for subjects to join; it was initially posted on May 20th 2022 and revised on July 22nd 2022. The research team requires 20 participants from two venues."

Answered by AI

Who else is applying?

What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~10 spots leftby Apr 2026